We are live on ! Find out more
IMNN icon

Imunon
IMNN

15 hedge funds and large institutions have $539K invested in Imunon in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more capital invested

Capital invested by funds: $287K → $539K (+$252K)

0.07% less ownership

Funds ownership: 0.34% → 0.27% (-0.07%)

17% less funds holding

Funds holding: 18 → 15 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
15
Holders Change
-3
Holders Change %
-16.67%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Focus Partners Wealth
Focus Partners Wealth
Massachusetts
+$25.5K
2
Renaissance Technologies
Renaissance Technologies
New York
+$9.99K
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$105
4
Citigroup
Citigroup
New York
+$38

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$20.1K
2
HF
HRT Financial
New York
-$19K
3
VF
Virtu Financial
New York
-$18K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$15.5K
5
TSS
Two Sigma Securities
New York
-$9.41K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$174K +$9.99K +1,050 +15%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$109K – – –
BlackRock
3
BlackRock
New York
$95.5K -$257 -27 -0.6%
Vanguard Group
4
Vanguard Group
Pennsylvania
$80K -$1.61K -169 -4%
Focus Partners Wealth
5
Focus Partners Wealth
Massachusetts
$46K +$25.5K +2,683 New
State Street
6
State Street
Massachusetts
$23.5K – – –
TRCT
7
Tower Research Capital (TRC)
New York
$7.12K -$2.87K -301 -47%
Morgan Stanley
8
Morgan Stanley
New York
$2.67K -$1.19K -125 -50%
MRCM
9
M&R Capital Management
New Jersey
$546 – – –
Fidelity Investments
10
Fidelity Investments
Massachusetts
$238 +$105 +11 New
Group One Trading
11
Group One Trading
Illinois
$212 – – –
Wells Fargo
12
Wells Fargo
California
$120 – – –
FDCDDQ
13
Federation des caisses Desjardins du Quebec
Quebec, Canada
$108 – – –
Citigroup
14
Citigroup
New York
$75 +$38 +4 New
UBS Group
15
UBS Group
Switzerland
$34 -$4.28K -450 -100%
GPFA
16
Game Plan Financial Advisors
Ohio
$3 – – –
Osaic Holdings
17
Osaic Holdings
Arizona
$3 – – –
Citadel Advisors
18
Citadel Advisors
Florida
– -$20.1K -2,271 Closed
HF
19
HRT Financial
New York
– -$19K -2,190 Closed
VF
20
Virtu Financial
New York
– -$18K -1,983 Closed
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
– -$15.5K -1,753 Closed
TSS
22
Two Sigma Securities
New York
– -$9.41K -1,061 Closed
Bank of America
23
Bank of America
North Carolina
– -$93 -11 Closed

IMNN Hedge Fund Activity: Q1 2024 in Review

15 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q1 2024, worth a combined $539K — up 88% from $287K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of IMNN and 3 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 1 added.

The largest buyer was Focus Partners Wealth, opening a new position worth an estimated $25.5K. The largest seller was Citadel Advisors, exiting entirely with an estimated $20.1K sold.

  • 15 institutional investors held Imunon (IMNN) as of Q1 2024, down from 18 in Q4 2023.
  • Funds reported $539K of Imunon stock for Q1 2024, up 88% quarter-over-quarter.
  • 3 funds opened new Imunon positions in Q1 2024 and 6 closed out, a net change of -3 holders.
  • The largest Imunon buyer in Q1 2024 was Focus Partners Wealth, an estimated $25.5K added.
  • The largest Imunon seller in Q1 2024 was Citadel Advisors, an estimated $20.1K sold.

Based on aggregated 13F filings for Q1 2024.